Epigenomics (journal)
 | |
Abbreviated title (ISO 4) | Epigenomics |
|---|---|
| Discipline | Epigenomics |
| Language | English |
| Edited by | James G. Herman, Jörg Tost |
| Publication details | |
| Publisher |
Future Medicine Ltd |
Publication history | 2009–present |
| Frequency | 8/year |
| 4.649 | |
| Indexing | |
| ISSN |
1750-1911 (print) 1750-192X (web) |
| CODEN | EPIGC7 |
| OCLC no. | 746948365 |
| Links | |
Epigenomics is a peer-reviewed medical journal established in 2009 and published by Future Medicine. The editors-in-chief are James G. Herman (University of Pittsburgh Cancer Institute) and Jörg Tost (Centre national de génotypage). The journal covers all aspects of research on epigenomics and epigenetics and their implications for diagnosis, prognosis and therapeutics.
Abstracting and indexing
The journal is abstracted and indexed in EMBASE/Excerpta Medica, Index Medicus/MEDLINE/PubMed, Chemical Abstracts, BIOSIS Previews, Science Citation Index Expanded, and Scopus. According to the Journal Citation Reports, the journal has a 2014 impact factor of 4.649, ranking it 31st out of 167 journals in the category "Genetics & Heredity".[1]
References
- ↑ "Journals Ranked by Impact: Genetics & Heredity". 2014 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2015.
External links
This article is issued from Wikipedia - version of the Tuesday, September 01, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.